 <h1>Simulect Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>basiliximab</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about basiliximab. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Simulect.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to basiliximab: intravenous powder for solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Intravenous route (Powder for Solution)</p><p>Only physicians experienced in immunosuppression therapy and management of organ transplantation patients should prescribe basiliximab. The physician responsible for basiliximab administration should have complete information requisite for the follow-up of the patient. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, basiliximab (the active ingredient contained in Simulect) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Check with your doctor as soon as possible if any of the following side effects occur while taking basiliximab:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal pain</li>
<li>back pain</li>
<li>coughing</li>
<li>dizziness</li>
<li> fever or chills</li>
<li>loss of energy or weakness</li>
<li>painful urination</li>
<li>shortness of breath </li>
<li>sore throat</li>
<li>swelling of the ankles, body, face, feet or lower legs</li>
<li>trembling or shaking of the hands or feet</li>
<li>vomiting</li>
<li>white patches in the mouth or throat or on the tongue</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abnormal vision</li>
<li>agitation</li>
<li>anxiety</li>
<li>bleeding, tender, or enlarged gums</li>
<li>blood in the stool</li>
<li> bruising</li>
<li>chest pain</li>
<li>depression </li>
<li>difficulty in urinating</li>
<li> fatigue</li>
<li>itching</li>
<li>numbness or pain in the legs</li>
<li>skin rash</li>
<li> sores in the mouth</li>
<li>“stocking and gloves” sensation of the hands or feet</li>
<li>tingling</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of basiliximab may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Acne</li>
<li>constipation</li>
<li> diarrhea</li>
<li>headache</li>
<li>heartburn </li>
<li>nausea</li>
<li>trouble in sleeping </li>
<li>weight gain</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Excessive hair growth</li>
<li>joint pain</li>
<li>muscle pain</li>
</ul><p>
<!-- end intravenous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to basiliximab: intravenous powder for injection</i></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Peripheral edema (29%), hypertension (27%), general edema (21%)</p>
<p><b>Common</b> (1% to 10%): Chest pain, face edema, leg edema, abnormal heart sounds, angina pectoris, cardiac failure, hypotension, arrhythmia, atrial fibrillation, tachycardia</p>
<p><b>Postmarketing reports</b>: Capillary leak syndrome<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (26%)</p>
<p><b>Common</b> (1% to 10%): Hematoma, hemorrhage, purpura, thrombocytopenia, thrombosis, polycythemia, leukopenia</p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Severe acute hypersensitivity reactions (including anaphylaxis)</p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infection, sepsis</p>
<p><b>Postmarketing reports</b>: Cytokine release syndrome</p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, arthropathy, back pain, bone fracture, cramps, hernia, myalgia, leg pain</p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Cataract, conjunctivitis, abnormal vision</p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyperkalemia (22%), hypercholesterolemia (11%), hypokalemia, hyperglycemia, hypophosphatemia, hyperuricemia</p>
<p><b>Common</b> (1% to 10%): Acidosis, dehydration, diabetes mellitus, fluid overload, hyperlipidemia, hypertriglyceridemia, hypocalcemia, hypoglycemia, hypomagnesemia, hypoproteinemia, weight increase</p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (24%)</p>
<p><b>Common</b> (1% to 10%): Agitation, anxiety, depression</p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infection (46%)</p>
<p><b>Common</b> (1% to 10%): Unspecified bladder disorders, genital edema, impotence, ureteral disorder, urinary retention, oliguria</p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (20%), rhinitis, dyspnea</p>
<p><b>Common</b> (1% to 10%): Bronchitis, bronchospasm, abnormal chest sounds, coughing, pharyngitis, pneumonia, pulmonary disorder, pulmonary edema, rhinitis, sinusitis</p>
<p><b>Postmarketing reports</b>: Respiratory failure</p><h3>Other</h3><p><b>Very common</b> (10% or more): Pain (42%), fever (20%)</p>
<p><b>Common</b> (1% to 10%): Asthenia, malaise</p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (24%), tremor (19%)</p>
<p><b>Common</b> (1% to 10%): Rigors, dizziness, neuropathy, paresthesia, hypoesthesia</p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Albuminuria, bladder disorder, dysuria, frequent micturition, hematuria, increased non-protein nitrogen, abnormal renal function, renal tubular necrosis</p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hypertrichosis, surgical wound complication, acne</p>
<p><b>Common</b> (1% to 10%): Cyst, herpes simplex, herpes zoster, hypertrichosis, pruritus, rash, skin disorder, skin ulceration</p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Increased glucocorticoids</p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Constipation (48%), nausea (34%), abdominal pain (21%), diarrhea (21%), vomiting (20%), dyspepsia</p>
<p><b>Common</b> (1% to 10%): Enlarged abdomen, esophagitis, flatulence, GI disorder, gastroenteritis, GI hemorrhage, gum hyperplasia, melena, moniliasis, ulcerative stomatitis</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Simulect (basiliximab)." Novartis Pharmaceuticals, East Hanover, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Simulect (basiliximab)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: interleukin inhibitors</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Simulect &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Organ Transplant, Rejection Prophylaxis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to basiliximab: intravenous powder for injection</i></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Peripheral edema (29%), hypertension (27%), general edema (21%)</p><p><b>Common</b> (1% to 10%): Chest pain, face edema, leg edema, abnormal heart sounds, angina pectoris, cardiac failure, hypotension, arrhythmia, atrial fibrillation, tachycardia</p><p><b>Postmarketing reports</b>: Capillary leak syndrome<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (26%)</p><p><b>Common</b> (1% to 10%): Hematoma, hemorrhage, purpura, thrombocytopenia, thrombosis, polycythemia, leukopenia</p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Severe acute hypersensitivity reactions (including anaphylaxis)</p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infection, sepsis</p><p><b>Postmarketing reports</b>: Cytokine release syndrome</p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, arthropathy, back pain, bone fracture, cramps, hernia, myalgia, leg pain</p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Cataract, conjunctivitis, abnormal vision</p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyperkalemia (22%), hypercholesterolemia (11%), hypokalemia, hyperglycemia, hypophosphatemia, hyperuricemia</p><p><b>Common</b> (1% to 10%): Acidosis, dehydration, diabetes mellitus, fluid overload, hyperlipidemia, hypertriglyceridemia, hypocalcemia, hypoglycemia, hypomagnesemia, hypoproteinemia, weight increase</p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (24%)</p><p><b>Common</b> (1% to 10%): Agitation, anxiety, depression</p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infection (46%)</p><p><b>Common</b> (1% to 10%): Unspecified bladder disorders, genital edema, impotence, ureteral disorder, urinary retention, oliguria</p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (20%), rhinitis, dyspnea</p><p><b>Common</b> (1% to 10%): Bronchitis, bronchospasm, abnormal chest sounds, coughing, pharyngitis, pneumonia, pulmonary disorder, pulmonary edema, rhinitis, sinusitis</p><p><b>Postmarketing reports</b>: Respiratory failure</p><h3>Other</h3><p><b>Very common</b> (10% or more): Pain (42%), fever (20%)</p><p><b>Common</b> (1% to 10%): Asthenia, malaise</p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (24%), tremor (19%)</p><p><b>Common</b> (1% to 10%): Rigors, dizziness, neuropathy, paresthesia, hypoesthesia</p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Albuminuria, bladder disorder, dysuria, frequent micturition, hematuria, increased non-protein nitrogen, abnormal renal function, renal tubular necrosis</p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hypertrichosis, surgical wound complication, acne</p><p><b>Common</b> (1% to 10%): Cyst, herpes simplex, herpes zoster, hypertrichosis, pruritus, rash, skin disorder, skin ulceration</p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Increased glucocorticoids</p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Constipation (48%), nausea (34%), abdominal pain (21%), diarrhea (21%), vomiting (20%), dyspepsia</p><p><b>Common</b> (1% to 10%): Enlarged abdomen, esophagitis, flatulence, GI disorder, gastroenteritis, GI hemorrhage, gum hyperplasia, melena, moniliasis, ulcerative stomatitis</p><p id="ref_1">1. "Product Information. Simulect (basiliximab)." Novartis Pharmaceuticals, East Hanover, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Simulect (basiliximab)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: interleukin inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Simulect &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Organ Transplant, Rejection Prophylaxis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>